Operating Lease, Right-of-Use Asset of Gossamer Bio, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Gossamer Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Gossamer Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,354,000, a 28% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Gossamer Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,354,000 -$1,672,000 -28% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $4,568,000 +$2,906,000 +175% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $4,775,000 +$2,371,000 +99% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $5,111,000 +$1,980,000 +63% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $6,026,000 +$2,181,000 +57% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,662,000 -$2,884,000 -63% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $2,404,000 -$2,830,000 -54% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $3,131,000 -$2,778,000 -47% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $3,845,000 -$2,727,000 -41% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,546,000 -$2,676,000 -37% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $5,234,000 -$2,627,000 -33% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $5,909,000 +$432,000 +7.9% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $6,572,000 +$261,000 +4.1% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $7,222,000 -$1,599,000 -18% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $7,861,000 -$1,831,000 -19% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $5,477,000 -$5,073,000 -48% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 $6,311,000 -$5,083,000 -45% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $8,821,000 -$1,471,000 -14% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $9,692,000 -$45,000 -0.46% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $10,550,000 +$247,000 +2.4% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 $11,394,000 +$534,000 +4.9% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $10,292,000 -$1,115,000 -9.8% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $9,737,000 -$2,185,000 -18% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $10,303,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $10,860,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $11,407,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $11,922,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.